← Open Payments lookup

DAVID PORTER: Open Payments

NPI 1386139285 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,708 in 43 payments from 14 companies in 2025. Trend: 2023 $597 · 2024 $2,548 · 2025 $3,708

Consulting: $2,849Food & beverage: $747Education: $111
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.3$2,916
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$170
ABBVIE INC.9$135
Teva Pharmaceuticals USA, Inc.2$129
Otsuka America Pharmaceutical, Inc.4$80
Axsome Therapeutics, Inc.3$61
Neurocrine BioSciences, Inc.2$40
E.R. Squibb & Sons, L.L.C.2$35
Alkermes, Inc.2$33
Edwards Lifesciences Corporation1$31

Products named: REJOYN, CAPLYTA, VRAYLAR, REXULTI, Auvelity, INGREZZA, COBENFY, ARISTADA.

Industry payments across NY — which companies pay providers there.